Artificial intelligence tools that could revolutionise patient care are being trialled in phase 2 of the Medicines and ...
Enterome has received fast track designation from the US Food and Drug Administration for its lead OncoMimics immunotherapy EO2463, targeting follicular lymphoma in the low tumour burden ...
The National Institute for Health and Care Research (NIHR) has announced a £157 million investment over 5 years to support 10 ...
Adocia and Tonghua Dongbao have announced positive topline results from a phase 3 clinical trial of BioChaperone Lispro ...
Kainos has announced a new contract of up to three years with NHS England to enhance digital preventative healthcare services ...
Eligible patients in Scotland with relapsed or refractory multiple myeloma will now have access to a new treatment option ...
Patients in the UK are set to benefit from a strengthened partnership between the Medicines and Healthcare products ...
Herantis Pharma has announced positive topline results from its phase 1b trial of HER-096 in people living with Parkinson’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback